Cancer chemotherapy update - Gemcitabine and erlotinib (GE) regimen for pancreatic cancer

Jessica Lee, James Waddell, Dominic Solimando

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Original languageEnglish (US)
Pages (from-to)19-23
Number of pages5
JournalHospital Pharmacy
Volume47
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

gemcitabine
Chemotherapy
Poisons
Pancreatic Neoplasms
Pharmacists
Antineoplastic Agents
Drug Therapy
Neoplasms
Therapeutics
Erlotinib Hydrochloride

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Cancer chemotherapy update - Gemcitabine and erlotinib (GE) regimen for pancreatic cancer. / Lee, Jessica; Waddell, James; Solimando, Dominic.

In: Hospital Pharmacy, Vol. 47, No. 1, 01.01.2012, p. 19-23.

Research output: Contribution to journalArticle

@article{4978c01c525b441e9407654908684cfc,
title = "Cancer chemotherapy update - Gemcitabine and erlotinib (GE) regimen for pancreatic cancer",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.",
author = "Jessica Lee and James Waddell and Dominic Solimando",
year = "2012",
month = "1",
day = "1",
doi = "10.1310/hpj4701-19",
language = "English (US)",
volume = "47",
pages = "19--23",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "1",

}

TY - JOUR

T1 - Cancer chemotherapy update - Gemcitabine and erlotinib (GE) regimen for pancreatic cancer

AU - Lee, Jessica

AU - Waddell, James

AU - Solimando, Dominic

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

UR - http://www.scopus.com/inward/record.url?scp=84855470532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855470532&partnerID=8YFLogxK

U2 - 10.1310/hpj4701-19

DO - 10.1310/hpj4701-19

M3 - Article

VL - 47

SP - 19

EP - 23

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 1

ER -